AF
GOSS icon

Amalgamated Financial’s Gossamer Bio GOSS Stock Holding History

Amalgamated Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$65K Buy
+94
New +$72.5K ﹤0.01% 2297

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Amalgamated Financial's GOSS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Gossamer Bio (GOSS) in Q1 2022: 94 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings.

139 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • Amalgamated Financial held 94 shares of Gossamer Bio worth $65K as of Q1 2022.
  • Gossamer Bio was a new Amalgamated Financial position in Q1 2022.
  • Gossamer Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2297 holding.
  • 139 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.